Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Biochemistry
|
August 31, 1993
Mechanism of inhibition of human leucocyte elastase by monocyclic beta-lactams
R Chabin, B G Green, P Gale, et al.
Biochemistry
|
June 2, 1992
Mechanism of inhibition of human leukocyte elastase by two cephalosporin derivatives
W B Knight, A L Maycock, B G Green, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 14, 1999
Potent, orally absorbed glucagon receptor antagonists
S E de Laszlo, C Hacker, B Li, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 15, 1993
Chemical, biochemical, pharmacokinetic, and biological properties of L-680,833: a potent, orally active monocyclic beta-lactam inhibitor of human polymorphonuclear leukocyte elastase
J B Doherty, S K Shah, P E Finke, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 11, 2001
Substituted imidazoles as glucagon receptor antagonists
L L Chang, K L Sidler, M A Cascieri, et al.
Journal of Medicinal Chemistry
|
October 26, 1992
Orally active beta-lactam inhibitors of human leukocyte elastase-1. Activity of 3,3-diethyl-2-azetidinones
S K Shah, C P Dorn, P E Finke, et al.
Journal of Medicinal Chemistry
|
March 19, 1993
Orally active beta-lactam inhibitors of human leukocyte elastase. 2. Effect of C-4 substitution
W K Hagmann, A L Kissinger, S K Shah, et al.
The Journal of Biological Chemistry
|
March 20, 1999
Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor
M A Cascieri, G E Koch, E Ber, et al.
Protein Science : a Publication of the Protein Society
|
October 1, 1995
Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme
J W Becker, A I Marcy, L L Rokosz, et al.
Nature Structural Biology
|
February 1, 1994
The NMR structure of the inhibited catalytic domain of human stromelysin-1
P R Gooley, J F O'Connell, A I Marcy, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Biochemistry
|
August 31, 1993
Mechanism of inhibition of human leucocyte elastase by monocyclic beta-lactams
R Chabin, B G Green, P Gale, et al.
Biochemistry
|
June 2, 1992
Mechanism of inhibition of human leukocyte elastase by two cephalosporin derivatives
W B Knight, A L Maycock, B G Green, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 14, 1999
Potent, orally absorbed glucagon receptor antagonists
S E de Laszlo, C Hacker, B Li, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 15, 1993
Chemical, biochemical, pharmacokinetic, and biological properties of L-680,833: a potent, orally active monocyclic beta-lactam inhibitor of human polymorphonuclear leukocyte elastase
J B Doherty, S K Shah, P E Finke, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 11, 2001
Substituted imidazoles as glucagon receptor antagonists
L L Chang, K L Sidler, M A Cascieri, et al.
Journal of Medicinal Chemistry
|
October 26, 1992
Orally active beta-lactam inhibitors of human leukocyte elastase-1. Activity of 3,3-diethyl-2-azetidinones
S K Shah, C P Dorn, P E Finke, et al.
Journal of Medicinal Chemistry
|
March 19, 1993
Orally active beta-lactam inhibitors of human leukocyte elastase. 2. Effect of C-4 substitution
W K Hagmann, A L Kissinger, S K Shah, et al.
The Journal of Biological Chemistry
|
March 20, 1999
Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor
M A Cascieri, G E Koch, E Ber, et al.
Protein Science : a Publication of the Protein Society
|
October 1, 1995
Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme
J W Becker, A I Marcy, L L Rokosz, et al.
Nature Structural Biology
|
February 1, 1994
The NMR structure of the inhibited catalytic domain of human stromelysin-1
P R Gooley, J F O'Connell, A I Marcy, et al.
Page
of 3